Cite
HARVARD Citation
Gentileschi, S. et al. (2020). Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis. Mediators of inflammation. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gentileschi, S. et al. (2020). Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis. Mediators of inflammation. p. . [Online].